查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662634

2030 年生物相容性 3D 列印材料市场预测：按模式、材料类型、技术、应用、最终用户和地区进行全球分析

Biocompatible 3D Printing Materials Market Forecasts to 2030 - Global Analysis By Form (Powder, Filament, Resins, Bioinks and Other Forms), Material Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生物相容性 3D 列印材料市场预计在 2024 年将达到 12 亿美元，到 2030 年将达到 40 亿美元，预测期内的复合年增长率为 21.9%。

生物相容性 3D 列印意味着使用与活组织相容的材料创建3D结构。这些材料与人体接触时不会引起任何不良反应，适用于植入、矫正器具、组织支架及药物传递系统等医疗应用。该过程需要精确列印亲和性材料，以创建自订解决方案，从而促进与生物系统的整合并改善医疗保健中的患者结果。

根据美国卫生与公众服务部的数据，医院使用基本电子健康记录(EHR) 系统的比率已从 2008 年的 9.4% 增加到 2021 年的 96%，标誌着数位化健康解决方案正在发生重大转变。

对医疗保健和医疗设备的需求不断增加

医疗保健和医疗设备领域对生物相容性 3D 列印的需求日益增长，其驱动力来自于个人化、自订的植入、义肢和手术器械的需求。这项技术可以製定针对患者的具体解决方案，从而改善治疗效果。此外，它还支持再生医学和组织工程的进步，为创建功能性和生物相容性结构提供了新的可能性。因此，医疗保健行业正在迅速采用 3D 列印用于医疗应用。

产业认知和采用有限

工业界对生物相容性 3D 列印技术的认识和采用有限，阻碍了其在医疗保健领域的广泛应用。许多医疗保健提供者尚未充分了解 3D 列印的潜力，从而减缓了其临床应用。这可能会延迟客製化植入、义肢和再生疗法的好处。此外，对新技术采用的抵制可能会阻碍市场充分发挥其成长潜力，限制创新并减少获得先进医疗解决方案的机会。

3D 列印材料的进步

新兴的3D列印材料对于市场发展至关重要，它能够推动开发满足医疗应用严格要求的新型聚合物、金属和陶瓷。这些创新使得适用于植入、矫正器具和组织工程的耐用、灵活且亲和性的材料成为可能。随着材料性能的改进，3D 列印在医学领域的应用范围将不断扩大，从而实现更大程度的客製化并改善患者的治疗效果。

技术复杂性

生物相容性 3D 列印技术复杂，需要熟练的劳动力、先进的设备和专业知识，这可能会限制其广泛应用。这使得小型医疗保健提供者和製造商在没有大量投资的情况下难以采用该技术。此外，复杂的设计、印刷和后处理过程可能会延长生产时间并增加成本，从而限制医疗领域的效率和可扩展性并减缓市场成长。

COVID-19 的影响

这个市场透过创造个人化的医疗设备、植入和义肢正在彻底改变医疗保健。透过客製化解决方案改善患者治疗效果并加速再生医学和组织工程的进步。此外，该技术还提高了生产效率、降低了成本并加速了治疗创新。然而，高成本、技术复杂性和监管障碍等挑战可能会影响市场潜力。

预计长丝市场在预测期内将占最大份额

预计预测期内长丝部分将占据最大的市场占有率。这些细丝由生物相容性聚合物、金属或陶瓷製成，对人类使用安全，旨在促进组织整合。长丝技术的创新提高了强度、灵活性和生物活性，为客製化医疗解决方案开闢了新的可能性。然而，材料限制和製造成本对广泛应用构成了挑战。

预计预测期内组织工程领域将以最高的复合年增长率成长。

预计预测期内组织工程领域将呈现最高的成长率。 3D 列印可以精确设计模仿自然组织的结构，从而推动再生医学的进步。透过使用生物相容性材料，这些列印支架可以促进癒合并最终有助于器官替换。该技术在治疗损伤和疾病方面具有巨大的潜力，但在材料开发和监管部门核准面临挑战。

比最大的地区

在预测期内，由于先进的医疗保健基础设施和个人化医疗设备的需求不断增加，预计北美将占据最大的市场占有率。美国和加拿大在植入、义肢和组织工程的 3D 列印应用方面处于领先地位。监管支援以及生物相容性材料的技术进步进一步推动了市场成长。然而，高成本和技术复杂性对该地区的广泛采用构成了挑战。

复合年增长率最高的地区

预计预测期内亚太地区将呈现最高的复合年增长率。印度和东南亚等新兴经济体医疗领域的扩张促进了手术规划模型、植入和矫正器具等医疗应用对 3D 列印的需求。此外，3D列印在该地区用于生产牙科植入、助听器和人工关节的应用也越来越普遍。

提供免费客製化

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生物相容性 3D 列印材料市场（按类型）

  • 介绍
  • 粉末
  • 灯丝
  • 树脂
  • 生物墨水
  • 其他的

5. 全球生物相容性 3D 列印材料市场（依材料类型）

  • 介绍
  • 聚合物
  • 金属
  • 陶瓷製品
  • 复合材料
  • 其他的

7. 全球生物相容性 3D 列印材料市场（依技术划分）

  • 介绍
  • 熔融沈积成型 (FDM)
  • 立体光刻技术(SLA)
  • 选择性雷射烧结 (SLS)
  • 生物列印

8. 全球生物相容性 3D 列印材料市场（按应用）

  • 介绍
  • 医疗植入
  • 组织工程
  • 义肢
  • 药物输送系统
  • 手术器械
  • 其他的

第九章。

  • 介绍
  • 医院和诊所
  • 研究所
  • 医疗设备製造商
  • 学术机构
  • 其他的

第 10 章全球生物相容性 3D 列印材料市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Stratasys Ltd.
  • 3D Systems
  • Materialise NV
  • Formlabs
  • Sculpteo
  • Carbon, Inc.
  • EnvisionTEC
  • EOS GmbH
  • BASF 3D Printing Solutions
  • HP Inc.
  • Tethon 3D
  • Protolabs
  • Optomec
  • Regemat 3D
  • Fiocruz
Product Code: SMRC28495

According to Stratistics MRC, the Global Biocompatible 3D Printing Materials Market is accounted for $1.2 billion in 2024 and is expected to reach $4.0 billion by 2030 growing at a CAGR of 21.9% during the forecast period. Biocompatible 3D printing is the use of materials that are compatible with living tissue to create three-dimensional structures. These materials do not cause harmful reactions when in contact with the human body, making them suitable for medical applications such as implants, prosthetics, tissue scaffolds, and drug delivery systems. The process involves precise printing of bio-friendly materials to create custom-made solutions that can promote healing, integration with biological systems, and improve patient outcomes in healthcare.

According to the United States Department of Health and Human Services, the use of basic Electronic Health Record (EHR) systems in hospitals went from 9.4% in 2008 to 96% in 2021 demonstrating a significant move toward digital health solutions.

Market Dynamics:

Driver:

Increasing demand in healthcare and medical devices

The increasing demand for biocompatible 3D printing in healthcare and medical devices is driven by the need for personalized, custom-fit implants, prosthetics, and surgical tools. This technology enables the creation of patient-specific solutions, improving treatment outcomes. Additionally, it supports advancements in regenerative medicine and tissue engineering, offering new possibilities for creating functional, biocompatible structures. As a result, the healthcare sector is rapidly adopting 3D printing for medical applications.

Restraint:

Limited industry awareness and adoption

Limited industry awareness and adoption of biocompatible 3D printing technology hinders its widespread use in healthcare. Many healthcare providers may not fully understand its potential, leading to slow integration into clinical practice. This can delay the benefits of customized implants, prosthetics, and regenerative treatments. Additionally, resistance to adopting new technologies can prevent the market from realizing its full growth potential, limiting innovation and reducing access to advanced medical solutions.

Opportunity:

Advances in 3D printing materials

Advances in 3D printing materials are crucial for the market, enabling the development of new polymers, metals, and ceramics that meet the stringent requirements of medical applications. These innovations allow for more durable, flexible, and bio-friendly materials suitable for implants, prosthetics, and tissue engineering. As material properties improve, the scope of 3D printing in healthcare expands, fostering greater customization and enhancing patient outcomes in medical treatments.

Threat:

Technical complexity

The technical complexity of biocompatible 3D printing can hinder its widespread adoption, as it requires skilled labor, advanced equipment, and specialized knowledge. This makes the technology difficult to implement for smaller healthcare providers or manufacturers without significant investment. Additionally, the intricate design, printing, and post-processing steps can lead to longer production times and increased costs, limiting efficiency and scalability in the healthcare sector, and slowing market growth.

Covid-19 Impact:

The market is revolutionizing healthcare by enabling the creation of personalized medical devices, implants, and prosthetics. It enhances patient outcomes through customized solutions, while fostering advancements in regenerative medicine and tissue engineering. Additionally, the technology improves production efficiency, reduces costs, and accelerates innovation in medical treatments. However, challenges such as high costs, technical complexity, and regulatory hurdles can impact its full market potential.

The filament segment is expected to be the largest during the forecast period

The filament segment is expected to account for the largest market share during the forecast period. These filaments, made from biocompatible polymers, metals, or ceramics, are designed to be safe for human use and promote tissue integration. Innovations in filament technology improve strength, flexibility, and bioactivity, expanding the possibilities for customized medical solutions. However, material limitations and production costs still present challenges for widespread adoption.

The tissue engineering segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the tissue engineering segment is predicted to witness the highest growth rate. 3D printing allows for the precise design of structures mimicking natural tissues, enabling advancements in regenerative medicine. By using biocompatible materials, these printed scaffolds promote healing and may eventually aid in organ replacement. This technology holds great promise for treating injuries and diseases but faces challenges in material development and regulatory approval.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by advanced healthcare infrastructure and increasing demand for personalized medical devices. The U.S. and Canada lead in adopting 3D printing for implants, prosthetics, and tissue engineering. Regulatory support, alongside technological advancements in biocompatible materials, is further accelerating market growth. However, high costs and technical complexities remain challenges for widespread adoption in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. The expansion of the healthcare sector in emerging economies such as India and Southeast Asia is contributing to the demand for 3D printing in medical applications, including surgical planning models, implants, and orthotic devices. Additionally, the use of 3D printers in the production of dental implants, hearing aids, and joint replacements is becoming more widespread in the region.

Key players in the market

Some of the key players in Biocompatible 3D Printing Materials market include Stratasys Ltd., 3D Systems, Materialise NV, Formlabs, Sculpteo, Carbon, Inc., EnvisionTEC, EOS GmbH, BASF 3D Printing Solutions, HP Inc., Tethon 3D, Protolabs, Optomec, Regemat 3D and Fiocruz.

Key Developments:

In September 2024, Fiocruz made an investment in affordable, open-source 3D bioprinters developed in partnership with the Oswaldo Cruz Institute and Veiga de Almeida University. This technology was intended to produce artificial biological tissues for various applications, including biomedical research, healthcare, and the food industry, utilizing bioink rather than conventional printing materials.

In April 2024, Materialise and Renishaw announced a partnership to enhance efficiency and productivity for manufacturers using Renishaw's RenAM 500 series of additive manufacturing systems. This collaboration provides Renishaw users access to Materialise's advanced build processor software and Magics for data preparation, enabling a streamlined workflow from design to finished part, while optimizing production time and operations.

Forms Covered:

  • Powder
  • Filament
  • Resins
  • Bioinks
  • Other Forms

Material Types Covered:

  • Polymers
  • Metals
  • Ceramics
  • Composites
  • Other Material Types

Technologies Covered:

  • Fused Deposition Modeling (FDM)
  • Stereolithography (SLA)
  • Selective Laser Sintering (SLS)
  • Bioprinting

Applications Covered:

  • Medical Implants
  • Tissue Engineering
  • Prosthetics
  • Drug Delivery Systems
  • Surgical Instruments
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Research Institutes
  • Medical Device Manufacturers
  • Academic Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biocompatible 3D Printing Materials Market, By Form

  • 5.1 Introduction
  • 5.2 Powder
  • 5.3 Filament
  • 5.4 Resins
  • 5.5 Bioinks
  • 5.6 Other Forms

5 Global Biocompatible 3D Printing Materials Market, By Material Type

  • 6.1 Introduction
  • 6.2 Polymers
  • 6.3 Metals
  • 6.4 Ceramics
  • 6.5 Composites
  • 6.6 Other Material Types

7 Global Biocompatible 3D Printing Materials Market, By Technology

  • 7.1 Introduction
  • 7.2 Fused Deposition Modeling (FDM)
  • 7.3 Stereolithography (SLA)
  • 7.4 Selective Laser Sintering (SLS)
  • 7.5 Bioprinting

8 Global Biocompatible 3D Printing Materials Market, By Application

  • 8.1 Introduction
  • 8.2 Medical Implants
  • 8.3 Tissue Engineering
  • 8.4 Prosthetics
  • 8.5 Drug Delivery Systems
  • 8.6 Surgical Instruments
  • 8.7 Other Applications

9 Global Biocompatible 3D Printing Materials Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Clinics
  • 9.3 Research Institutes
  • 9.4 Medical Device Manufacturers
  • 9.5 Academic Institutions
  • 9.6 Other End Users

10 Global Biocompatible 3D Printing Materials Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Stratasys Ltd.
  • 12.2 3D Systems
  • 12.3 Materialise NV
  • 12.4 Formlabs
  • 12.5 Sculpteo
  • 12.6 Carbon, Inc.
  • 12.7 EnvisionTEC
  • 12.8 EOS GmbH
  • 12.9 BASF 3D Printing Solutions
  • 12.10 HP Inc.
  • 12.12 Tethon 3D
  • 12.12 Protolabs
  • 12.13 Optomec
  • 12.14 Regemat 3D
  • 12.15 Fiocruz

List of Tables

  • Table 1 Global Biocompatible 3D Printing Materials Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Biocompatible 3D Printing Materials Market Outlook, By Form (2022-2030) ($MN)
  • Table 3 Global Biocompatible 3D Printing Materials Market Outlook, By Powder (2022-2030) ($MN)
  • Table 4 Global Biocompatible 3D Printing Materials Market Outlook, By Filament (2022-2030) ($MN)
  • Table 5 Global Biocompatible 3D Printing Materials Market Outlook, By Resins (2022-2030) ($MN)
  • Table 6 Global Biocompatible 3D Printing Materials Market Outlook, By Bioinks (2022-2030) ($MN)
  • Table 7 Global Biocompatible 3D Printing Materials Market Outlook, By Other Forms (2022-2030) ($MN)
  • Table 8 Global Biocompatible 3D Printing Materials Market Outlook, By Material Type (2022-2030) ($MN)
  • Table 9 Global Biocompatible 3D Printing Materials Market Outlook, By Polymers (2022-2030) ($MN)
  • Table 10 Global Biocompatible 3D Printing Materials Market Outlook, By Metals (2022-2030) ($MN)
  • Table 11 Global Biocompatible 3D Printing Materials Market Outlook, By Ceramics (2022-2030) ($MN)
  • Table 12 Global Biocompatible 3D Printing Materials Market Outlook, By Composites (2022-2030) ($MN)
  • Table 13 Global Biocompatible 3D Printing Materials Market Outlook, By Other Material Types (2022-2030) ($MN)
  • Table 14 Global Biocompatible 3D Printing Materials Market Outlook, By Technology (2022-2030) ($MN)
  • Table 15 Global Biocompatible 3D Printing Materials Market Outlook, By Fused Deposition Modeling (FDM) (2022-2030) ($MN)
  • Table 16 Global Biocompatible 3D Printing Materials Market Outlook, By Stereolithography (SLA) (2022-2030) ($MN)
  • Table 17 Global Biocompatible 3D Printing Materials Market Outlook, By Selective Laser Sintering (SLS) (2022-2030) ($MN)
  • Table 18 Global Biocompatible 3D Printing Materials Market Outlook, By Bioprinting (2022-2030) ($MN)
  • Table 19 Global Biocompatible 3D Printing Materials Market Outlook, By Application (2022-2030) ($MN)
  • Table 20 Global Biocompatible 3D Printing Materials Market Outlook, By Medical Implants (2022-2030) ($MN)
  • Table 21 Global Biocompatible 3D Printing Materials Market Outlook, By Tissue Engineering (2022-2030) ($MN)
  • Table 22 Global Biocompatible 3D Printing Materials Market Outlook, By Prosthetics (2022-2030) ($MN)
  • Table 23 Global Biocompatible 3D Printing Materials Market Outlook, By Drug Delivery Systems (2022-2030) ($MN)
  • Table 24 Global Biocompatible 3D Printing Materials Market Outlook, By Surgical Instruments (2022-2030) ($MN)
  • Table 25 Global Biocompatible 3D Printing Materials Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 26 Global Biocompatible 3D Printing Materials Market Outlook, By End User (2022-2030) ($MN)
  • Table 27 Global Biocompatible 3D Printing Materials Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 28 Global Biocompatible 3D Printing Materials Market Outlook, By Research Institutes (2022-2030) ($MN)
  • Table 29 Global Biocompatible 3D Printing Materials Market Outlook, By Medical Device Manufacturers (2022-2030) ($MN)
  • Table 30 Global Biocompatible 3D Printing Materials Market Outlook, By Academic Institutions (2022-2030) ($MN)
  • Table 31 Global Biocompatible 3D Printing Materials Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.